Lee Ainslie Quest Diagnostics Inc Transaction History

Maverick Capital LTD

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$130.56 - $146.84 $326,791 - $367,540	2,503 Added 45.16%	8,046 $1.13 Million
Q1 2023 May 15, 2023	BUY	$131.53 - $155.76 $729,070 - $863,377	5,543 New	5,543 $784,000
Q2 2021 Aug 16, 2021	SELL	$126.66 - $141.48 $309,177 - $345,352	-2,441 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$114.63 - $133.34 $207,824 - $241,745	1,813 Added 288.69%	2,441 $313,000
Q4 2020 Feb 16, 2021	BUY	$112.7 - $128.05 $70,775 - $80,415	628 New	628 $75,000

924

95.1M

361K

346K

Ticker DGX
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 113,887,000
Market Cap $15.6B
Description
Quest Diagnostics Incorporated provides diagnostic testing, information, and services in the United States and internationally. The company develops and delivers diagnostic information services, such as routine testing, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services. It offers dia...

Get notified when there are updates to the investment portfolio of Maverick Capital LTD, based on Form 13F filings with the SEC.

Stay updated on Maverick Capital LTD and Lee Ainslie with notifications on news.